Literature DB >> 11952286

Pityriasis versicolor.

A K Gupta1, R Bluhm, R Summerbell.   

Abstract

UNLABELLED: Pityriasis versicolor is a common superficial fungal infection of the skin. It is caused by Malassezia spp., which are normal human saprophytes. Under certain conditions, both exogenous and endogenous, the fungus can convert from a yeast to a pathogenic mycelial form. This alteration results in mild inflammation of the skin, and in characteristic clinical and histological changes. The taxonomy of Malassezia spp. has recently been modified to include six obligatorily lipophilic species, all of which can be found on human skin, plus one non-obligatorily lipophilic species, which only rarely colonizes human hosts. LEARNING
OBJECTIVES: At the conclusion of this learning activity, participants should be aware of the role of Malassezia in the development of pityriasis versicolor, the clinical and histological changes arising from this dermatosis, and the diagnosis and treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952286     DOI: 10.1046/j.1468-3083.2002.00378.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  14 in total

Review 1.  [Malassezia yeasts and their significance in dermatology].

Authors:  W Hort; M Nilles; P Mayser
Journal:  Hautarzt       Date:  2006-07       Impact factor: 0.751

2.  Uncommon presentations of tinea versicolor.

Authors:  Sowmya Varada; Tushar Dabade; Daniel S Loo
Journal:  Dermatol Pract Concept       Date:  2014-07-31

3.  Clinical and epidemiological features of the genus Malassezia in Iran.

Authors:  Elham Zeinali; Golnar Sadeghi; Fahimeh Yazdinia; Masoomeh Shams-Ghahfarokhi; Mehdi Razzaghi-Abyaneh
Journal:  Iran J Microbiol       Date:  2014-10

4.  SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL.

Authors:  Daiane Heidrich; Tatiane Caroline Daboit; Cheila Denise Ottonelli Stopiglia; Cibele Massotti Magagnin; Gerson Vetoratto; Taís Guarienti Amaro; Maria Lúcia Scroferneker
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

5.  Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.

Authors:  Shaimaa El-Housiny; Maii Atef Shams Eldeen; Yasmina Ahmed El-Attar; Hoda A Salem; Dalia Attia; Ehab R Bendas; Mohamed A El-Nabarawi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

6.  Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran.

Authors:  Bita Tarazooie; Parivash Kordbacheh; Farideh Zaini; Kamiar Zomorodian; Farshid Saadat; Hojjat Zeraati; Zahra Hallaji; Sassan Rezaie
Journal:  BMC Dermatol       Date:  2004-05-01

7.  Molecular identification and prevalence of malassezia species in pityriasis versicolor patients from kashan, iran.

Authors:  Rezvan Talaee; Farzad Katiraee; Maryam Ghaderi; Mahzad Erami; Azam Kazemi Alavi; Mehdi Nazeri
Journal:  Jundishapur J Microbiol       Date:  2014-08-01       Impact factor: 0.747

8.  Exploration of anti-Malassezia potential of Nyctanthes arbor-tristis L. and their application to combat the infection caused by Mala s1 a novel allergen.

Authors:  Rohit K Mishra; Vani Mishra; Anand Pandey; Amit K Tiwari; Himanshu Pandey; Shivesh Sharma; Avinash C Pandey; Anupam Dikshit
Journal:  BMC Complement Altern Med       Date:  2016-03-31       Impact factor: 3.659

Review 9.  Antifungal Treatment for Pityriasis Versicolor.

Authors:  Aditya K Gupta; Kelly A Foley
Journal:  J Fungi (Basel)       Date:  2015-03-12

10.  Cutaneous disorders of adolescence among Nigerian secondary school students.

Authors:  Jadesola Tryphena Oyedepo; Oludolapo Sherifat Katibi; Olanrewaju Timothy Adedoyin
Journal:  Pan Afr Med J       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.